VHPB Centre for Evaluation of Vaccination (CEV) |
Executive Secretary Administrative and Scientific Secretariat |
privacy statement
|
Lisbon, Portugal, November 18-19, 2010
Thursday, November 18, 2010
Session 1 Opening and objectives
Chair: Francisco George, Rui Tato Marinho
Session 2 Overview of health care system and communicable disease prevention and control in Portugal
Chair: Carlos Orta E Gomes, Rui Tato Marinho
09.30 – 10.00
Reforms in health system: “The Health Transformation Programme” in Portugal 419 Kb (.pdf)
Francisco George
10.00 – 10.20
Viral hepatitis surveillance system in Portugal 71 Kb (.pdf)
Mário Carreira
10.20 – 10.45 Coffee Break
Session 3 Epidemiology of viral hepatitis in Portugal
Chair: Fernando Ramalho, Claire Cameron
10.45 – 11.05
The epidemiological situation of hepatitis B 1.6 Mb (.pdf)
Rui Tato Marinho
11.05 – 11.25
The epidemiological situation of hepatitis E in Portugal 560 Kb (.pdf)
Sara Folgado Alberto
11.25 – 11.45
The epidemiological situation of hepatitis C in Portugal 676 Kb (.pdf)
Paula Peixe
11.45 – 12.05 Discussion
12.05 – 13.30 Lunch
Chair: Leopoldo Matos, Heléne Norder
13.30 – 13.50
Molecular epidemiology of viral hepatitis C in Portugal 1 Mb (.pdf)
António Martinho
13.50 – 14.10
Molecular epidemiology of viral hepatitis B in Portugal 0.9 Mb (.pdf)
Ana Paula Mota
14.10 – 14.30
Epidemiology of viral hepatitis in pediatric patients
Ana Isabel Lopes - hepatitis C 752 Kb(.pdf)
Gonçalo Cordeiro Ferreira>- hepatitis B - 76 Kb (.pdf)
14.30 – 14.50 Discussion
14.50 – 15.05 Coffee break
Session 4 Review of progress achieved in hepatitis prevention and control in Portugal
Chair: Guilherme Macedo,Alessandro Zanetti
15.05 – 15.25
The epidemiology of hepatitis A in Portugal: targeted vaccination versus universal immunization 250 Kb (.pdf)
Sandra Guedes
15.25 – 15.45
Viral hepatitis in haemodyalisis 3.3 Mb (.pdf)
Armando Carvalho
15.45 – 16.05
Liver Patients Association vision and activities 1.6 Mb (.pdf)
Emília Rodrigues
16.05 –16.25
The Syringe Exchange Programme in Portugal 3.3 Mb (.pdf)
Carla Torre
16.25 – 16.45
HBV immunization policies and lessons learnt after 10 years 559 Kb (.pdf)
Paula Valente
16.45 – 17.05 Discussion
17.05 End of the Day
Friday, November 19, 2010
Session 5 Different aspects of viral hepatitis in Portugal
Chair: Jorge Areias, John Ward
09.00 – 09.20
Viral hepatitis and pregnancy. 1.3 Mb (.pdf)
Cristina Guerreiro
09.20 – 09.40
Epidemiology of coinfection (HIV, HCV) in Portugal. 702 KB (pdf)
Rui Sarmento e Castro
09.40 – 10.00
Liver transplant and viral hepatitis in Portugal 1.6 Mb (.pdf)
Eduardo Barroso
0.00 – 10.20
Economic aspects of viral hepatitis and liver disease in Portugal 430 Kb (.pdf)
José Giria
10.20 – 10.40 Discussion
10.40 – 11.00 Coffee break
Session 6 Evaluation of viral hepatitis prevention and control measures
Chair:José Velosa, Daniel Shouval
11.00 – 11.20
Results from the blood bank screening in Portugal 576 Kb (.pdf)
Gabriel de Olim
11.20 – 11.40
The epidemiology of viral hepatitis in Portuguese IV drug addiction 1.3 Mb (.pdf)
José Pádua,João Goulão
11.40 – 12.00
Can Portugal learn from France? 103 Kb (.pdf)
Françoise Roudot-Thoraval
Impact of the hepatitis resolution adopted by the World Health Assembly (WHA 63.18) 368 Kb (.pdf)
Steven Wiersma
12.20 – 12.30 Discussion
12.30 – 14.00 Lunch
Session 7 Conclusions of the meeting
Chair: M. Carneiro de Moura , Mark Kane
14.15 – 14.45
Key note lecture: viral hepatitis 697 Kb(.pdf)
Daniel Lavanchy
14.45 – 15.15
Presentation of the VHPB meeting conclusions 94 Kb (.pdf)
D. FitzSimons
15.15 Close of the meeting